These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34234163)

  • 1. Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer.
    Kirkham AA; Haykowsky MJ; Beaudry RI; Grenier JG; Mackey JR; Pituskin E; Paterson DI; Thompson RB
    Sci Rep; 2021 Jul; 11(1):14005. PubMed ID: 34234163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise Intolerance in Anthracycline-Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition.
    Beaudry RI; Kirkham AA; Thompson RB; Grenier JG; Mackey JR; Haykowsky MJ
    Oncologist; 2020 May; 25(5):e852-e860. PubMed ID: 31951302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients.
    Howden EJ; Bigaran A; Beaudry R; Fraser S; Selig S; Foulkes S; Antill Y; Nightingale S; Loi S; Haykowsky MJ; La Gerche A
    Eur J Prev Cardiol; 2019 Feb; 26(3):305-315. PubMed ID: 30376366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness.
    Foulkes S; Costello BT; Howden EJ; Janssens K; Dillon H; Toro C; Claus P; Fraser SF; Daly RM; Elliott DA; Conyers R; La Gerche A
    J Cardiovasc Magn Reson; 2020 Sep; 22(1):64. PubMed ID: 32892749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer survivors with preserved or rescued cardiorespiratory fitness have similar cardiac, pulmonary and muscle function compared to controls.
    Grigoriadis G; Sherman SR; Lima NS; Lefferts EC; Hibner BA; Ozemek HC; Danciu OC; Kanaloupitis D; Fernhall B; Baynard T
    Eur J Appl Physiol; 2022 Oct; 122(10):2189-2200. PubMed ID: 35796827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic Fitness Is Related to Myocardial Fibrosis Post-Anthracycline Therapy.
    Kirkham AA; Paterson DI; Haykowsky MJ; Beaudry RI; Mackey JR; Pituskin E; Grenier JG; Thompson RB
    Med Sci Sports Exerc; 2021 Feb; 53(2):267-274. PubMed ID: 32826630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Changes in Skeletal Muscle Metabolism, Oxygen Uptake, and Myosteatosis During Cardiotoxic Treatment for Early-Stage Breast Cancer.
    Kirkham AA; Pituskin E; Mackey JR; Grenier JG; Ian Paterson D; Haykowsky MJ; Thompson RB
    Oncologist; 2022 Sep; 27(9):e748-e754. PubMed ID: 35579489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy.
    Foulkes SJ; Howden EJ; Bigaran A; Janssens K; Antill Y; Loi S; Claus P; Haykowsky MJ; Daly RM; Fraser SF; LA Gerche A
    Med Sci Sports Exerc; 2019 Aug; 51(8):1573-1581. PubMed ID: 30829962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of cardio-oncological rehabilitation and cardiorespiratory fitness in patients receiving cardiotoxic chemotherapy: a longitudinal observational study.
    Schneider C; Dierks A; Rabaglio M; Campbell KL; Wilhelm M; Eser P
    Swiss Med Wkly; 2024 Jun; 154():3588. PubMed ID: 38885132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study.
    Foulkes SJ; Howden EJ; Haykowsky MJ; Antill Y; Salim A; Nightingale SS; Loi S; Claus P; Janssens K; Mitchell AM; Wright L; Costello BT; Lindqvist A; Burnham L; Wallace I; Daly RM; Fraser SF; La Gerche A
    Circulation; 2023 Feb; 147(7):532-545. PubMed ID: 36342348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired Cardiac and Skeletal Muscle Energetics Following Anthracycline Therapy for Breast Cancer.
    Gamble DT; Ross J; Khan H; Unger A; Cheyne L; Rudd A; Saunders F; Srivanasan J; Kamya S; Horgan G; Hannah A; Baliga S; Tocchetti CG; Urquhart G; Linke WA; Masannat Y; Mustafa A; Fuller M; Elsberger B; Sharma R; Dawson D
    Circ Cardiovasc Imaging; 2023 Oct; 16(10):e015782. PubMed ID: 37847761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.
    Tham EB; Haykowsky MJ; Chow K; Spavor M; Kaneko S; Khoo NS; Pagano JJ; Mackie AS; Thompson RB
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):48. PubMed ID: 23758789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiorespiratory fitness in breast cancer patients undergoing adjuvant therapy.
    Klassen O; Schmidt ME; Scharhag-Rosenberger F; Sorkin M; Ulrich CM; Schneeweiss A; Potthoff K; Steindorf K; Wiskemann J
    Acta Oncol; 2014 Oct; 53(10):1356-65. PubMed ID: 24837860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of exercise-based tests for estimating cardiorespiratory fitness and muscle strength in early-stage breast cancer survivors in Japan.
    Tsuji K; Matsuoka YJ; Kuchiba A; Suto A; Ochi E
    Support Care Cancer; 2022 May; 30(5):3857-3863. PubMed ID: 35037120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.
    Kirkham AA; Paterson DI; Prado CM; Mackey JR; Courneya KS; Pituskin E; Thompson RB
    BMC Cancer; 2018 Sep; 18(1):864. PubMed ID: 30176834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of exercise training on cardiac toxicity markers in women with breast cancer undergoing chemotherapy with anthracyclines: a randomized controlled trial.
    Antunes P; Joaquim A; Sampaio F; Nunes C; Ascensão A; Vilela E; Teixeira M; Capela A; Amarelo A; Marques C; Viamonte S; Alves A; Esteves D
    Eur J Prev Cardiol; 2023 Jul; 30(9):844-855. PubMed ID: 36857149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes.
    Nesti L; Pugliese NR; Sciuto P; De Biase N; Mazzola M; Fabiani I; Trico D; Masi S; Natali A
    Cardiovasc Diabetol; 2021 Jun; 20(1):124. PubMed ID: 34158062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracycline-Associated T1 Mapping Characteristics Are Elevated Independent of the Presence of Cardiovascular Comorbidities in Cancer Survivors.
    Jordan JH; Vasu S; Morgan TM; D'Agostino RB; Meléndez GC; Hamilton CA; Arai AE; Liu S; Liu CY; Lima JA; Bluemke DA; Burke GL; Hundley WG
    Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27502058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired pulmonary oxygen uptake kinetics and reduced peak aerobic power during small muscle mass exercise in heart transplant recipients.
    Jendzjowsky NG; Tomczak CR; Lawrance R; Taylor DA; Tymchak WJ; Riess KJ; Warburton DE; Haykowsky MJ
    J Appl Physiol (1985); 2007 Nov; 103(5):1722-7. PubMed ID: 17717113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy.
    Beaudry RI; Howden EJ; Foulkes S; Bigaran A; Claus P; Haykowsky MJ; Gerche A
    Physiol Rep; 2019 Jan; 7(1):e13971. PubMed ID: 30632311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.